BEDFORD, Mass., March. 28, 2008 /PRNewswire-FirstCall/ -- Hologic, Inc. (NASDAQ: HOLX), a diversified medical technologies company specializing in diagnostics, imaging systems and interventional devices dedicated to serving the healthcare needs of women, confirmed the previously announced two-for-one stock split, to be effected in the form of a stock dividend. The record date for the stock split was March 21, 2008 and the payment date will be April 2, 2008. On the payment date, the transfer agent will mail certificates representing one additional share for each share held on March 21, 2008 (or otherwise record the ownership of these additional shares). The ex dividend ate for Hologic on the NASDAQ Global Select Market will be April 3, 2008. Hologic stockholders do not need to exchange their current stock certificates or take any other action to receive the split shares.
About Hologic, Inc.
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, and mini C-arm for extremity imaging.
Additional Information and Where to Find It
In connection with the proposed amendment to Hologic's Certificate of Incorporation, Hologic has filed a proxy statement with the Securities and Exchange Commission. Investors and security holders are advised to read such proxy statement because it contains important information. Information regarding the interests of the participants in the solicitation of proxies is described in the proxy statement. Investors and other security holders can obtain copies of the proxy statement free of charge by directing a request to Hologic, Inc., 35 Crosby Drive, Bedford, MA 01730, Telephone (781) 999-7300. You may also obtain free copies of the proxy statement by accessing the SEC's website at http://www.sec.gov.
Deborah R. Gordon
Vice President, Investor Relations
Director, Investor Relations